Evaluation of clinical symptom-guided partial neuromuscular blockade in COVID-19 patients

Evaluation of clinical symptom-guided partial neuromuscular blockade in COVID-19 patients - E-PNMB in COVID

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055035

Enrollment

Registered

2024-07-22

Start date

2024-07-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COVID-19

Exclusion criteria

Exclusion criteria: allergy against rocuronium neuromuscular disease no large spontaneous breathing

Design outcomes

Primary

Measure	Time frame
Dose of muscular relaxant, tidal volume, presence of reverse trigger, presence of spontaneous breathing, P0.1, TOF, PTC, Presence of backing, presence of diaphragmic costriction	—

Countries

Japan

Contacts

Public ContactSatoki Inoue

Nara Medical University Anesthesiology and Intenive care

seninoue@naramed-u.ac.jp0744223051

Outcome results